Company intelligence / Profile preview
Emcee Pharmaceuticals
- Ownership
- Private
- Development stage
- Other
Overview
Emcee Pharmaceuticals is an Indian pharmaceutical company focused on the manufacturing and marketing of a wide range of pharmaceutical formulations. Established in 1980, the company has built a strong presence in the domestic market, particularly in therapeutic areas such as anti-infectives, gastroenterology, and pain management. Its product portfolio includes well-known brands like Emclox, Emcef, and Empod, which are available in various dosage forms including tablets, capsules, and syrups. The company is committed to providing affordable healthcare solutions and maintains manufacturing facilities that adhere to quality standards to serve patients across India.
- Therapeutic areas
- GastroenterologyNeurologyInfectious DiseasesMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
9 assets8 more assets in the full pipeline.
Beyond the preview
Go deeper on Emcee Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Emcee Pharmaceuticals.